Rifaximin
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2079 publications
Evaluation of the Ligand-Dependent Coactivator Recruitment of the Nuclear Receptor Pregnane X Receptor Using Its Three-Alanine Residues-Inserted Mutant.
Journal: Biological & pharmaceutical bulletin
Published: June 21, 2026
Quantification of Changes in Bifidobacteria and Lactobacilli Colony-forming Units During Rifaximin Treatment and Synbiotic Gel in Healthy Volunteers.
Journal: Journal of visualized experiments : JoVE
Published: June 15, 2026
Muribaculum as a microbial contributor of rifaximin-induced mucosal protection during chemotherapy.
Journal: Gut microbes
Published: June 13, 2026
Editorial: Rifaximin and the Gut-Liver-Brain Axis-Progress and Prudence.
Journal: Alimentary pharmacology & therapeutics
Published: June 10, 2026
Therapy-refractory hepatic encephalopathy or acquired hepato-cerebral degeneration - a challenging differential diagnosis
Journal: Zeitschrift fur Gastroenterologie
Published: May 28, 2026
In vitro study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseases.
Journal: Gut microbes reports
Published: May 04, 2026
Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 13, 2026
A multi-compound dietary supplement to improve the well-being of symptomatic uncomplicated diverticular disease.
Journal: Minerva gastroenterology
Published: March 30, 2026
The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research.
Journal: Annals of medicine
Published: March 29, 2026
Last Updated: 06/30/2026